piracetam and vigilance

Piracetam and vigilance. A study of EEG changes and clinical effects in gerontopsychiatric patients
(author’s transl)

Bente D, Glatthaar G, Ulrich G, Lewinsky M.

Arzneimittelforschung 1978;28(9):1529-30

Abstract

The electroencephalographic and clinical effects of piracetam were studied in a group of 11 hospitalized gerontopsychiatric patients treated with a daily dosage of 4.8 g for 8–13 months. The EEG was evaluated by power spectral analysis, followed by a principal component analysis of frequency parameters. The statistical analysis of the resulting factor scores shows that piracetam induces significant EEG changes: decrease of slow frequencies, augmentation and acceleration of alpha-activity and increase of beta-activity. These EEG changes, indicating an increase in vigilance, correspond clinically to an improvement of communicative behavior and cognitive functioning.